Coronavirus vaccines aren't very far away at all, and the latest news is the Food and Drug Administration's approval of Pfizer's vaccine candidate.
The Food and Drug Administration (FDA) advisory committee has officially approved Pfizer, and BioNTech's coronavirus vaccine candidate for Emergency Use Authorization (EUA) after a vote of 17-4 was counted, with one committee member abstaining.
While the FDA has given Pfizer's vaccine EUA, that doesn't mean the candidate will begin to be rolled out to Americans. The vote now has to be reviewed by the Center for Biologics Evaluation and Research, who will confirm the decision. As for the effectiveness of the vaccine, in the late-stage clinical trials, it proved to be 95% effective at preventing a COVID-19 infection.
For more information on this story, visit this link here.
- > NEXT STORY: New Ghost n' Goblins Resurrected delivers unique picturebook visuals
- < PREVIOUS STORY: Cyberpunk 2077 huge on the PC, biggest PC game launch EVER